Regulatory News: Genomic Vision (Paris:GV) (FR0011799907 – GV, la « Société »), une société de biotechnologie cotée sur Euronext développant des produits et services dédiés à l’analyse et au...
Regulatory News: Genomic Vision (FR0011799907 – GV, éligible PEA-PME) (Paris:GV), société de biotechnologie cotée sur Euronext développant des produits et services dédiés à l’analyse et au...
FiberSmart® is Genomic Vision’s Artificial Intelligence (AI) powered and fully integrated software automating genomic analysis FiberSmart® leverages cutting-edge AI to rapidly analyze DNA...
Genomic Vision and CNRS launch a core oncology program with the Cancer Research Center of Marseille to develop companion tests based on TeloSizer® Regulatory News: Genomic Vision (Paris:GV...
Déclaration au titre de l’article 223-16 du règlement général de l’Autorité des marchés financiers Regulatory News: Genomic Vision (Paris:GV) : Date Nombre d’actions composant le capital Nombre...
Regulatory News: Genomic Vision (FR0011799907 – GV, – the “Company”) (Paris:GV), a Euronext-listed biotechnology company developing tools and services for the highly accurate characterization of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Symbol | Price | Vol. |
---|---|---|
AAPYKurv Yield Premium Strategy Apple AAPL ETF | $ 0.00 (0.00%) | 0 |
AAPXT Rex 2X Long Apple Daily Target ETF | $ 0.00 (0.00%) | 0 |
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | $ 0.00 (0.00%) | 0 |
AAAUGoldman Sachs Physical Gold ETF Shares | $ 0.00 (0.00%) | 0 |
AAAAlternative Access First Priority CLO Bond ETF | $ 0.00 (0.00%) | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.